Walleye Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-156
Closed -$8.97K 4419
2025
Q2
$8.97K Buy
+156
New +$12.5K ﹤0.01% 4320
2024
Q4
Sell
-868
Closed -$85.3K 4772
2024
Q3
$85.3K Sell
868
-1,000
-54% -$129K ﹤0.01% 4457
2024
Q2
$305K Sell
1,868
-164
-8% -$23.4K ﹤0.01% 3965
2024
Q1
$310K Buy
2,032
+1,824
+877% +$303K ﹤0.01% 3638
2023
Q4
$65.3K Buy
208
+92
+79% +$33.3K ﹤0.01% 4223
2023
Q3
$51.5K Buy
+116
New +$52.4K ﹤0.01% 4187

Other funds holding AGL

Walleye Capital's AGL Position: Q4 2025 in Review

Walleye Capital sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 563 shares — an estimated $14.5K sold.

Walleye Capital first reported a position in AGL in Q4 2021 and held it in 7 quarters. The position peaked at $1.23M in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Walleye Capital reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 563 Agilon Health shares in Q4 2025, an estimated $14.5K.
  • Walleye Capital first reported a position in Agilon Health in Q4 2021 and held it in 7 quarters.
  • Walleye Capital's Agilon Health position peaked at $1.23M in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.